Abiopharma

Perimeter Solutions SA (PRM) Reports Q4 2025 Financial Results Perimeter Solutions SA (PRM) announced its financial results for the period ending Q4 2025. Key Financial Highlights:

• Revenue: $140 million
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: $140 million
  • anticipated in any forward-looking statements, including the risk factors described from time to time by us in our filings with the Securities and Exchange Commission (“SEC”), including, but not limited to, the ability to receive the required regulatory approvals and satisfy other customary closing conditions in order to close the acquisition; the ultimate timing, outcome and results of integrating the operations of MMT and Perimeter; the ability of the combined company to realize anticipated benefits, including the expected leverage profile following completion of the acquisition, in the timeframe expected or at all; changes in capital markets and the ability of the combined company to finance operations in the manner expected; the effects of commodity prices; risks related to the demand for MMT and Perimeters services; and the other factors included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024